4//SEC Filing
REED VICKIE S 4
Accession 0001214659-22-000417
CIK 0001576263other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:50 PM ET
Size
5.4 KB
Accession
0001214659-22-000417
Insider Transaction Report
Form 4
REED VICKIE S
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2022-01-04$147.74/sh−758$111,987→ 10,870 total
Footnotes (2)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.
- [F2]The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $147.73 to $148.2832, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001405637
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:50 PM ET
- Size
- 5.4 KB